Cytology
Scientists at the Medical University of Lubeck, Institute of Physiology, have conducted a comprehensive review of the pleiotropic effects of erythropoietin (Epo), a protein hormone that plays a crucial role in red blood cell production. Beyond its well-known function in promoting erythropoiesis, Epo has been found to have significant effects
Cytology
Doctors continue to use blood transfusions to prevent strokes in young sickle cell patients, despite the treatment's risks, after a clinical study was halted due to severe complications. The STOP II study, initiated in 2000 and funded by the National Heart, Lung and Blood Institute, aimed to determine
Cytology
Research conducted by L.C. Jones and colleagues at the University of California Los Angeles, Cedars Sinai Medical Center has identified a significant decrease in RARbeta2 expression in patients suffering from myelofibrosis with myeloid metaplasia. This condition, a clonal stem-cell disorder, leads to ineffective hematopoiesis, bone marrow fibrosis, and extramedullary
Cytology
Researchers from the Medical College of Wisconsin, in collaboration with the National Marrow Donor Program, have conducted a new study confirming the viability and effectiveness of stem cells derived from umbilical cords as a transplant source for leukemia patients with no other treatment options. According to Mary Horowitz, MD, senior
Neurosciences
Nonobese diabetic (NOD) mice spontaneously develop autoimmune diabetes, and researchers have found that dendritic cells (DC) play a crucial role in this autoimmune response. Studies have reported defective DC generation in vitro from NOD mouse bone marrow, but a deviated development of myeloid precursors into non-dendritic cells in response to
Neurosciences
Scientists in the United States and Japan have discovered that papillomavirus-like particles (HPV16 VLPs) can stimulate murine immune responses, including the production of alpha interferon (IFN-alpha) and Th1 immune responses. These findings suggest that HPV16 VLPs can be recognized by dendritic cells, leading to the activation of various defense responses.
Cytology
Allogeneic stem cell transplantation, either with reduced intensity or conventional therapy, poses a significant risk of invasive aspergillosis (IA). A study from Japan analyzed the clinical characteristics of IA after reduced-intensity stem cell transplantation (RIST) compared with conventional stem cell transplantation (CST). The findings indicate that IA occurs later following
Cytology
Research from the United States has revealed that hypoxia triggers stem cell proliferation, followed by neuronal progenitor cell differentiation. This process may potentially replace lost neurons. The study, published in Brain Research, found that hypoxic stress induces apoptosis of hippocampal CA1 neurons while sparing those in CA2-3. The researchers examined
Cytology
Recent research from the United States has found that pulmonary histopathology after allogeneic bone marrow transplantation is accompanied by endothelial cell apoptosis. This conclusion was reached through a well-established murine BMT system, in which lung injury and graft-versus-host disease are induced by minor histocompatibility antigenic differences between donor and host.
Cytology
Researchers from the Medical College of Georgia (MCG) and the University of South Florida (USF) have made a groundbreaking discovery in the treatment of stroke, utilizing cord blood stem cells in conjunction with a temporary breach of the brain's protective barrier. According to their study published in the
Cytology
Researchers at the University of Zurich have made a groundbreaking discovery in the field of neuroscience, identifying genes that are induced by glial cell line-derived neurotrophic factor (GDNF) overproduction in neuronal progenitor cells. GDNF is a protein involved in the development and maintenance of neural tissues, and its dysregulation has
Cytology
HuMax-CD4, a high-affinity human antibody developed by Genmab, A/S, has been designated as an orphan drug by the U.S. Food and Drug Administration (FDA) for the treatment of Mycosis Fungoides (MF), a type of cutaneous T-cell lymphoma (CTCL) affecting approximately 16,000-20,000 individuals in the United States.
